Can neurosyphilis mimic Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Neurosyphilis can indeed mimic Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in its clinical presentation. Neurosyphilis, the tertiary stage of syphilis infection affecting the nervous system, can present with symptoms similar to CIDP including progressive weakness, sensory abnormalities, and areflexia. The key difference is that neurosyphilis is caused by Treponema pallidum infection, while CIDP is an immune-mediated disorder.

Key Diagnostic Considerations

  • Diagnosis of neurosyphilis requires serological testing including VDRL or RPR, followed by more specific tests like FTA-ABS or TP-PA, and cerebrospinal fluid analysis showing pleocytosis, elevated protein, and positive VDRL, as indicated by the CDC guidelines 1.
  • The CSF-VDRL is specific but not sensitive, and a reactive test establishes the diagnosis of neurosyphilis but a nonreactive test does not exclude the diagnosis, highlighting the importance of comprehensive diagnostic approaches.

Treatment Implications

  • Treatment for neurosyphilis consists of intravenous penicillin G for 10-14 days, or alternative regimens for patients who cannot receive IV therapy, emphasizing the need for targeted antibiotic therapy rather than immunosuppression.
  • Proper diagnosis is crucial as treating neurosyphilis with immunosuppressants (standard for CIDP) would be ineffective and allow progression of the infection, underscoring the importance of distinguishing between these conditions.

Clinical Considerations

  • Clinicians should consider syphilis testing in any patient with CIDP-like presentation, especially those with atypical features, risk factors for syphilis, or other signs of syphilis infection, to ensure accurate diagnosis and appropriate management.

From the Research

Clinical Manifestations of Neurosyphilis

  • Neurosyphilis can cause diverse clinical pictures that are occasionally similar to other neurological diseases 2
  • The forms of presentation of neurosyphilis can be grouped into two categories: early (asymptomatic, meningeal, and meningovascular neurosyphilis) and late (progressive general paralysis and tabes dorsalis) 2
  • Neurosyphilis can mimic other diseases, including Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), due to its clinical polymorphism 2

Diagnosis and Treatment of Neurosyphilis

  • Diagnosis of neurosyphilis is complex and based on the study of cerebrospinal fluid, with T. pallidum serology playing a key role 2
  • Penicillin G is the recommended treatment for neurosyphilis, but ceftriaxone may be an acceptable alternative 3
  • High-dose intravenous penicillin G can be effective in treating symptomatic neurosyphilis in patients with HIV infection, but the response to treatment may vary 4

Neuroimaging Features of Neurosyphilis

  • Neuroimaging is essential to demonstrate abnormal brain or spinal cord findings in patients with neurosyphilis, aiding in diagnosis, treatment, and follow-up 5
  • Neurosyphilis can cause various neuroimaging patterns, including cerebral gummas and medial temporal lobe abnormalities, which can mimic other diseases 3, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Neurosyphilis.

Continuum (Minneapolis, Minn.), 2015

Research

Imaging features of neurosyphilis.

Journal of neuroradiology = Journal de neuroradiologie, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.